Targeting the Small- and Intermediate-Conductance Ca²⁺-Activated Potassium Channels: The Drug-Binding Pocket at the Channel/Calmodulin Interface

Abstract

The small- and intermediate-conductance Ca²⁺-activated potassium (SK/IK) channels play important roles in the regulation of excitable cells in both the central nervous and cardiovascular systems. Evidence from animal models has implicated SK/IK channels in neurological conditions such as ataxia and alcohol use disorders. Further, genome-wide association studies have suggested that cardiovascular abnormalities such as arrhythmias and hypertension are associated with single nucleotide polymorphisms that occur within the genes encoding the SK/IK channels. The Ca²⁺ sensitivity of the SK/IK channels stems from a constitutively bound Ca²⁺-binding protein: calmodulin. Small-molecule positive modulators of SK/IK channels have been developed over the past decade, and recent structural studies have revealed that the binding pocket of these positive modulators is located at the interface between the channel and calmodulin. SK/IK channel positive modulators can potentiate channel activity by enhancing the coupling between Ca²⁺ sensing via calmodulin and mechanical opening of the channel. Here, we review binding pocket studies that have provided structural insight into the mechanism of action for SK/IK channel positive modulators. These studies lay the foundation for structure-based drug discovery efforts that can identify novel SK/IK channel positive modulators. © 2014 S. Karger AG, Basel

A defect in KCa3.1 channel activity limits the ability of CD8 + T cells from cancer patients to infiltrate an adenosine-rich microenvironment

“…KCa3.1 are Ca 2+ sensitive K + channels that open upon an increase in intracellular Ca 2+ concentration. 1-EBIO is a positive modulator of KCa3.1 channels, which increases their Ca 2+ sensitivity (41). Eil et al .…”

SK2 channels regulate mitochondrial respiration and mitochondrial Ca2+ uptake

“…[19][20][21] Dysfunction of potassium channels has been implicated in the pathogenesis of psychiatric disorders and neurodegenerative diseases such as schizophrenia and Alzheimer's disease or Parkinson's disease, respectively. [22][23][24] At the plasma membrane, SK channels reside in close proximity to NMDA receptors and mediate after-hyperpolarization thereby reducing neuronal excitability. Positive pharmacological SK channel modulation using CyPPA or NS309 protected neuronal cells in different paradigms of cell death triggered by H 2 O 2 , glutamate, 21,25 or ER stress 26 in vitro, and in models of cerebral ischemia in vivo.…”

Platelet-derived growth factor receptor alpha-positive cells: a new cell type in the human ureteropelvic junction

“…In addition, it has been shown that a positive modulation of SK channels can lower blood pressure in animal models of hypertension. Thus, SK channels have been demonstrated as potent therapeutic targets for the treatment of hypertension (23). However, to our knowledge, no study has thoroughly investigated the effects of potential SK channel therapeutics in the upper urinary tract.…”